Sunday, July 5, 2026

HomeHealth NewsThree-drug combo targets immune suppression to overcome melanoma resistance

Three-drug combo targets immune suppression to overcome melanoma resistance

- Advertisement -

Figure 5b from the paper shows the difference between tumors treated with just an antibody and vehicle (solution) or with trametinib and rigosertib and a CD40 agonist. Credit: Nature Communications (2026). DOI: 10.1038/s41467-025-67315-1

For patients with advanced melanoma without BRAF mutation who no longer respond to immune…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed